ZAGREB, June 11 (Hina) - A leading Croatian pharmaceutical company "Pliva" on Tuesday announced the conclusion of a final agreement with the Sobel company on the acquisition of the entire ownership over a pharmaceutical company
"Sidmak Laboratories" and its daughter-company "Odyssey Pharmaceuticals" at the price of 152.9 million US dollars and with the take-over of a loan worth USD59 million.
ZAGREB, June 11 (Hina) - A leading Croatian pharmaceutical company
"Pliva" on Tuesday announced the conclusion of a final agreement
with the Sobel company on the acquisition of the entire ownership
over a pharmaceutical company "Sidmak Laboratories" and its
daughter-company "Odyssey Pharmaceuticals" at the price of 152.9
million US dollars and with the take-over of a loan worth USD59
million. #L#
The Sidmak and Odyssey companies, based in East Hannover, New
Jersey, are drug companies that produce generic and so-called
speciality pharmaceuticals.
The acquisition of Sidmak and Odyssey will bring many financial and
strategic benefits to the Croatian firm such as the direct access to
the American market.
(hina) ms